Template - UHN Presentation - CANO-ACIO
Transcription
Template - UHN Presentation - CANO-ACIO
Facing the FACT Together: The nursing leadership team and staff oncology nurses join forces in meeting the accreditation standards for the lymphohematopoietic stem cell transplant program Kalia, V., Cordon, C., Incekol, D., Simon, S., Pringle, N., Dean, R., Robinson, S., Wright, J., Simpson, L., Harmon, P., Patel, B., Weekes, D., Eduard Cojocari Breen, D. & Willson, B. Abstract • The Foundation for the Accreditation of Cellular Therapy (FACT) establishes international standards for hematopoietic progenitor cells isolated from bone marrow or peripheral blood including all phases of collection, processing, and administration of these cells (The Foundation for the Accreditation of Cellular Therapy, 2006). FACT requires all nurses working in the lymphohematopoietic stem cell transplant (LSCT) program to have formal initial training and continuous education with evidence of training related to the nursing care of LSCT patients at any point in their treatment. In one teaching hospital, nurses working within the LSCT program had varying clinical experience ranging from novice to expert, which posed as a challenge in meeting FACT requirements. It was difficult to identify the type of training these nurses had received. Although they were all trained at some point in their career, their training was not standardized, sometimes sporadic and not properly documented. Several LSCT nurses in leadership roles and staff nurses collaborated and identified strategies to address this challenge. In February 2010, the LSCT Program successfully received accreditation. In this presentation we will discuss our journey, the different innovative educational opportunities that surfaced out of this challenge, the lessons learned and future plans to ensure that FACT requirements are continuously met. Overview • • • • • • • PMH BMT Program FACT Accreditation Requirements for nurses The challenges How we met our challenges Lessons Learned Celebrating our success Look at me! Look at me! Look at me NOW! It is fun to have fun But you have to know how (Dr. Seuss, 1957) The Bone Marrow Transplant program at PMH • Established in 1971 • Has some of the longest surviving bone marrow transplant recipients in the world • The first in Canada to perform allogeneic transplants and transplants between unrelated donors. • Perform about 70 allogeneic transplants per year and about 190 autologous transplants per year (UHN, 2010) The Bone Marrow Transplant program at PMH • Outpatient clinics – Ambulatory clinics – Systemic Therapy (Chemotherapy outpatient and Transfusion outpatient units) • Inpatient units – Allogeneic stem cell transplant unit – Autologous stem cell transplant unit • Apheresis • Others (Coordinators, APNs, Managers, Clinical Trials) The Foundation for the Accreditation of Cellular Therapy (FACT) • FACT establishes international standards for hematopoietic progenitor cells isolated from bone marrow or peripheral blood including all phases of collection, processing, and administration of these cells (The Foundation for the Accreditation of Cellular Therapy, 2006). Accreditation Manual, 4th ed Our journey… http://www.solarnavigator.net/images/perfect_storm_big_wave.jpg Image retrieved from: http://www.neophobic.ro/art_img/adeline/11122008212133/panic_attack.jpg "This mess is too big and too deep and too tall. We can't clean it up! We can't clean it up at all!" (Dr. Seuss, 1957) Identifying the challenges • Standard Operating Procedures • Documentation of Training and Education for Nursing Staff – Development of standardized forms and tracking toolsto track Continuing Education Activities – Compilation of certificates & documentation that demonstrates participation in ongoing learning and have met training competencies and requirements of BMT program – Submission of certificates and checklist Collaborating and coming together "I know, up on top you are seeing great sights, but down here at the bottom we, too, should have rights." (Dr. Seuss, 1958) http://fazia.in2p3.fr/images/collaboration.gif Using a Shared Governance approach on a micro level What is Shared governance? • A dynamic process for achieving organizational effectiveness by promoting decision making and accountability for practice through empowerment. • It empowers nurses to contribute collaboratively to the decision making process related to nursing practice, practice standards and procedures. (Bednarski, 2009) Shared Governance continued • Theoretical underpinnings come from various perspectives that includes organizational, management, and sociological theories. • Used extensively in health care; with evidence to suggest improved financial status (cost savings or reductions), increase nursing satisfaction, and improved work environment (Anthony, 2004) Does shared governance work? “most nurse researchers have concluded that shared governance is good by its association with a sparkling array of outcomes and correlations……” (Hess, 2004) Image from: http://www.cartoonsto ck.com/lowres/shr131 9l.jpg Meeting FACT Requirements “Think left and think right And think low and think high Oh! The thinks you can think up if you only try!” (Dr. Seuss, 1975) http://www.blindsociety.com/blindspot/wpcontent/uploads/2008/12/think_outside_the_box_by_neh o.jpg Innovative educational opportunities Time Full day Sessions Topic Presenter/fac ilitator 0830-0840 Registration Introductions Charissa Cordon 0840-0900 Pre-test 0900-0930 Overview of hematopoiesis Cindy Murray 0930-1030 Leukemia (myeloid) Disease pathophysiology, treatment, side effects, symptom management, and nursing care Shanon Nixon 1045-1145 1145-1215 Leukemia (lymphoid) Disease pathophysiology, treatment, side effects, symptom management, and nursing care Case Study and discussion Cindy Murray 1315-1415 Multiple Myeloma Disease pathophysiology, treatment, side effects, symptom management, and nursing care Case Study/Group discussion Andrew Winter 1415-1515 Lymphoma Disease pathophysiology, treatment, side effects, symptom management, and nursing care Case Study/Group discussion 1530-1630 Aplastic Anemia Myelodysplastic Syndrome 1630-1700 Post-test, Evaluations and Wrap up Kathy Trip Time Topic Presenter 0800-0830 Pre-test 0830-0930 Comprehensive review of hematopoiesis and basic concepts of transplantation Hematopoiesis and immunology HSCT as a treatment option History of transplantation Types of transplantation Indications for a transplant Predictive factors for acute GVHD Ethical Considerations in HSC 0930-1015 Donor Identification and Stem Cell Collection Evaluation of allogeneic donors for collection (related, unrelated and mismatched donors) Blood stem cell collection Mobilization Apheresis Stem cell processing. Michelle Dougan, RN 1030-1115 Conditioning Regimens in HSCT Myeloablative vs. non-myeloablative Total body irradiation Sarah D’Angelo, APNE 1115-1200 Infusions of Cryopreserved and Fresh Hematopoietic Stem Cells: Implications for Inpatient RNs Baseline and ongoing assessments Complications FACT Accreditation Vandana Kalia, RN Allogeneic 1300-1400 Hematologic effects Charissa Cordon 1400-1500 Graft vs. Host Disease Classification and grading Prevention and treatment Gastrointestinal, hepatorenal, cardiopulmonary, skin and neurological complications of HSCT Janice Wright, 1515-1600 Post treatment follow-up Survivorship Relapse and secondary malignancies post HSCT Quality of Life issues Janice Wright, Full day Sessions Charissa Cordon Administration of Growth Factors Presented by: Charissa Cordon, APNE This learning activity has been generously sponsored by: When: Wednesday, May 20, 2009 Time: 1300-1345 & 1400-1445 (45 min of CE hours ) Location: PMH Nursing Center, (3-613) At the end of this presentation, participants will be able to: – List the hematopoietic growth factors available for clinical use at PMH – Identify the therapeutic effect of each growth factor – Enumerate the side effects of growth factors – List the clinical indications for each growth factor This learning activity meets one of the requirements for FACT Accreditation For further information, please contact: Charissa Cordon x 16-5928 Conditioning Regimens for Hematopoietic Stem Cell Transplantation Presented by: Sarah D’Angelo, APNE This learning activity has been generously sponsored by: When: Time: Location: Wednesday, April 29, 2009 1215-1300 & 1315-1400 (45 min of CE hours) PMH 14th Floor Classroom (14-742) Otsuka Pharmaceutical Group At the end of this presentation, participants will be able to: 1. Define the goals for Blood and Marrow Transplantation (BMT) conditioning regimes 2. Differentiate between allogeneic & autologous conditioning regimes 3. Discuss factors important for determining the type of conditioning regimen 4. Understand nursing management during conditioning 5. Discuss side effects of conditioning regimes and the associated nursing care **Lunch will be served. This learning activity meets one of the requirements for FACT Accreditation** For further information, please contact: Charissa Cordon x 16-5928 Snack and Learn: Beyond Survival: Managing Late Effect Complications of Allogenic Stem Cell Transplantation Presented by: Janice Wright, NP eLearning Courses Competency Validation Checklist: • A peer reviewed system that promotes professional accountability for the delivery of quality nursing care • An example of Shared Governance and enhanced professional accountability (Green & Jordan, 2004) Did Shared Governance work for us? ….because shared governance demands energy and attention from its participants, some nurses may decide to follow BUT not participate….. (Hess, 2004) Common deficiencies during on-site inspections for FACT Accreditation In clinical programs: – Inadequate data management * – Inadequate quality management plan* – Incomplete or absent SOPs* In collection facilities – Incomplete or absent SOPs* – Inadequate management of the results of donor evaluation findings and test results – Lack of documentation of adverse reaction reactions – Deficiencies in label applied to the product at the end of collection* In the lab services – – – – – Validation procedures/or records missing * Inappropriate labels HPC infusion documents HPC storage P&P incomplete Engraftment not tracked by laboratory (Warkentin et al, 2000) We GOT ACCREDITED!! "You'll be on your way up! You'll be seeing great sights! You'll join the high fliers who soar to high heights." (Dr. Seuss, 1990) Lessons Learned • Need to standardize approach to education, and training • Consistently reinforce SOPs and P&Ps • Consistently track education hours and training activities – Learner accountability Future plans • Continue with standardized approach • Continue to brain storm and find more effective ways to engage all staff on deeper level • Continue to work with foundation created with initial FACT work References Anthony, M. (2004). Shared Governance Models: The theory, practice and evidence. The Online Journal of Issues in Nurisng. 9(1).. Bednardski, D. (2009). Shared governance: enhancing nursing practice. Nephrology Nursing Journal. 36 (6). Dr. Seuss. (1957). The Cat in the Hat. New York: Random House Books Dr. Seuss. (1958). Yertle the Turtle and Other Stories. New York: Random House Books Dr. Seuss. (1975). Oh, The Thinks you can Think!. New York: Random House Books Dr. Seuss. (1990). Oh, The Places You’ll Go!. New York: Random House Books Green, A. & Jordan, C. (2004). Common denominators: Shared governance and work place advocacy- strategies for nurses to gain contraol over their practice. Online Journal of Issues in Nursing. 9(1). Hess, R. (2004). From bedside to boardroom- nursing shared governance. The Online Journal of Issues in Nursing. 9(1). University Health Network. (2010). Princess Margaret Hospital at a Glance. Website: www.uhn.on.ca Warkentin, P., Nick, L. & Shpall. E. (2000). FAHCT accreditation: common deficiencies during on-site inspections. Cryotherapy. 3(2), 213-220